TriSalus Life Sciences (NASDAQ:TLSIW) Trading 4.5% Higher – Here’s Why

Shares of TriSalus Life Sciences, Inc. (NASDAQ:TLSIW) rose 4.5% during trading on Thursday . The company traded as high as $0.65 and last traded at $0.6790. Approximately 2,983 shares were traded during trading, a decline of 44% from the average session volume of 5,330 shares. The stock had previously closed at $0.65.

TriSalus Life Sciences Price Performance

The firm has a 50-day moving average price of $0.78 and a 200 day moving average price of $1.17.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. Aristeia Capital L.L.C. bought a new position in TriSalus Life Sciences during the 4th quarter worth $43,000. Fort Baker Capital Management LP bought a new position in TriSalus Life Sciences in the fourth quarter valued at about $44,000. Cerity Partners LLC acquired a new position in TriSalus Life Sciences during the 4th quarter worth approximately $1,374,000. Finally, Citadel Advisors LLC increased its holdings in shares of TriSalus Life Sciences by 439.0% during the third quarter. Citadel Advisors LLC now owns 126,876 shares of the company’s stock worth $199,000 after buying an additional 103,336 shares in the last quarter.

About TriSalus Life Sciences

TriSalus Life Sciences, Inc is a clinical-stage medical device company focused on developing minimally invasive technologies to enhance the precision and efficacy of cancer radiation therapy. The company’s lead product, the TriMark™ Tissue Marker System, is designed to provide high-visibility soft-tissue fiducial markers that assist oncologists in accurately targeting tumors during radiotherapy. By deploying bio-absorbable markers directly into tumor beds, TriSalus aims to improve treatment planning, patient comfort and long-term follow-up imaging.

Founded in 2015 and headquartered in Plymouth, Minnesota, TriSalus Life Sciences pursues a platform approach to oncology treatment, with research and development efforts centered on novel delivery devices and advanced imaging solutions.